(Q85660596)
Statements
Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion (English)
Ashish V Kalra
Jaeyeon Kim
Stephan G Klinz
Nancy Paz
Jason Cain
Daryl C Drummond
Ulrik B Nielsen
Jonathan B Fitzgerald
1 October 2014